eP213: Phase 2 multiple ascending-dose study of SRP-5051 PPMO in patients with DMD amenable to exon 51 skipping: Part A resultsCraig Campbell, H. Phan, Marc van de Rijn et al.|Genetics in Medicine|2022Cited by 2